ALL COMPANIES

Azathioprine is an immunosuppressant used as a small molecule therapy. It suppresses the immune system’s activity, which may help to...

NT-0796 is a small molecule that acts as an inflammasome inhibitor and NLRP3 inhibitor. It aims to block neuroinflammation, thus...

NEU-411 is a small molecule that functions as a LRRK2 kinase inhibitor. It targets the LRRK2 (leucine-rich repeat kinase 2)...

ARV-102 is a small molecule that functions as a LRRK2 protein degrader. This means it works to degrade the LRRK2...

BIIB-094 is an antisense therapeutic designed to reduce LRRK2 levels through LRRK2 reduction. Antisense therapies work by interfering with the...

Bayer and BlueRock Therapeutics are collaborating to develop cell therapies for Parkinson’s disease. Their lead product is bemdaneprocel (BRT-DA01). It...

This company is developing autologous neuron replacement therapy in sporadic Parkinson’s disease, and a gene-corrected autologous neuron replacement therapy for...

A cell/tissue therapy using human amniotic epithelial stem cells to support neuron regeneration and slow progression. Stem cells are believed...

This therapy uses umbilical cord-derived mesenchymal stem cells for cell/tissue therapy. Stem cells are introduced to support neuron health and...